A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 5, 1996, Pages 1129-1140

  Merayo Lloves, Jesús ^a   Zhao, Tong Z ^a   Dutt, James E ^a   Stephen Foster, C ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Cytokines; hay fever conjunctivitis histopathology; IgE; nedocromil sodium; ragweed

Indexed keywords

ALLERGEN; NEDOCROMIL SODIUM;

AIRBORNE PARTICLE; ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HAY FEVER; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAGWEED;

EID: 0029886152     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70268-3     Document Type: Article

References (47)

1. Coca AF, Cooke RA. On the classification of the phenomena of hypersensitiveness. J Immunol 1923;8:163-82.
2. Donshik PC. Allergic conjunctivitis. Int Ophthalmol Clin 1989;29:294-302.
3. Abelson MB, Udell IJ, Allansmith MA, Raizman MB. Allergic and toxic reactions. In: Albert DM, Jacobiec FA, eds. Principles and practice of ophthalmology. Philadelphia: Saunders, 1994;1:77-100.
4. Von Pirquet CE. Allergy. Arch Intern Med 1911;7:259-88.
5. Abelson MB, Schaefer K. Conjunctivitis of allergic origin: immunological mechanism and current approaches to therapy. Surv Ophthalmol 1993;38(suppl):115-32.
6. Calonge M, Pastor JC, Herreras JM, González JL. Pharmacologic modulation of vascular permeability in ocular allergy in the rat. Invest Ophthalmol Vis Sci 1990;31:176-80.
7. Iso T, Nakajima N, Suda H, Yamauchi H, Uda K. Passive anaphylaxis in rat conjunctiva and topical effects of antiallergic agents: hypersensitivity in conjunctiva and drug efficacy. Ophthalmic Res 1980;12:9-15.
8. Allansmith MR, Bloch KJ, Baird RS, Sinclair K. Ocular anaphylaxis: induction by local injection of antigen. Immunology 1981:44:623-7.
9. Calonge M, Briggs RM, Levene RB, Saiga T, Bloch JK, Allansmith MR. Early and late phases of ocular anaphylaxis in actively immunized guinea pigs. Acta Ophthalmol 1990;68:470-6.
10. Friedlaender MH. Contact hypersensitivity in guinea pigs. In: Tabbara K, Cello RM, eds. Animal models of ocular diseases. Springfield, Illinois: Charles C. Thomas, 1984:263-8.
11. The Association for Research in Vision and Ophthalmology (ARVO). Statement for the Use of Animals in Ophthalmic and Vision Research. In: Handbook for the use of animals in biomedical research. Animals in Research Committee 2nd ed. Bethesda: The Association for Research in Vision and Opthalmology. 1993:15-6.
12. Ballas Z, Blumenthal M, Tinkelman D, et al. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993;38:141-8.
13. Merayo-Lloves J, Calonge M, Foster CS. Experimental model of ocular allergy in guinea pig. Curr Eye Res 1995;14:487-94.
14. Hoang-Xuan T, Rodriguez A, Zaltas M, Rice B, Foster CS. Ocular rosacea: an histologie and immunopathologic study. Ophthalmology 1990;97:1468-75.
15. Burstein HJ, Tepper RI, Abbas AK, et al. Humoral immune functions in IL-4 transgenic mice. J Immunol 1991;147:2950-5.
16. Kimata H, Mikawa H. Nedocromil sodium selectively inhibits IgE and IgG4 production in human B cells stimulated with IL-4. J Immunol 1993;151:6723-31.
17. Ausdenmoorc RW. Aeroallergens and environmental factors. In: Lawlor GJ, Thomas JF, eds. Manual of allergy and immunology. Boston: Little Brown and Company, 1988:36-45.
18. Schwartzman RM, Rockey JH, Halliwell RE. Canine reaginic antibody. Characterization of the spontaneous antiragweed and induced anti-dinitrophenyl reaginic antibodies of the atopic dog. Clin Exp Immunol 1971;9:549-69.
19. Saruya S. Studies on allergic conjunctivitis: effects of castration and sex hormone administration on experimental allergic conjunctivitis. Acta Soc Ophthalmol Japan 1968;72:833-45.
20. Revoltella R, Ovary Z. Reaginic antibody production in different mouse strains. Immunology 1969;17:45-54.
21. Levine BB, Vaz NM. Effect of combination of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse. Int Arch Allergy Appl Immunol 1970;39:156-71.
22. Vaz EM, Vaz NM, Levine BB. Persistent formation of reagins in mice injected with low dose of ovalbumin. Immunology 1971;21:11-5.
23. Merayo-Lloves J, Foster CS. Murine model of seasonal allergic conjunctivitis (SAC) to ragweed. In: Nussenblant RB, Whitcup SM, Caspi RR, Gery I, eds. Advances in ocular immunology. Amsterdam: Elsevier, 1994:107-10.
24. Doherty MJ, Easty DL. The comparison of conjunctival immediate hypersensitivity responses in three animal models: guinea pig, rat and mouse. In: Secchi AG, Fregona IA, eds. Modern trends in immunology and immunopathology of the eye. Milano: Masson, 1989:136-9.
25. Abelson MB, Madiwale N, Weslon JH. Conjunctival eosinophils in allergic ocular disease. Arch Ophthalmol 1983;101:555-6.
26. Butrus SI, Abelson MB. Laboratory evaluation of ocular allergy. Int Ophthalmol Clin 1988;28:324-8.
27. Austen KF. Diseases of immediate type hypersensitivity. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine. New York: McGraw Hill, 1994:1422-8.
28. Allansmith R, Baird RS, Bloch J. Degranulation of ocular mast cells in rats undergoing systemic anaphylaxis. Invest Ophthalmol Vis Sci 1980;19:1521-54.
29. Henriquez AS, Kenyon KR, Allansmith MR. Mast cell ultrastructure: comparison in contact lens-associated giant papillary conjunctivitis and vernal conjunctivitis. Arch Ophthalmol 1981;99:1266-72.
30. Morgan SJ, Williams JH, Walls AF, Church MK, Holgate ST, McGill JI. Mast cell number and staining characteristics in the normal and allergic human conjunctiva. J Allergy Clin Immunol 1991;87:111-6.
31. Allansmith MR, Baird RS. Percentage of degranulated mast cell in vernal conjunctivitis and giant papillary conjunctivitis associated with contact lens wear. Am J Ophthalmol 1981;9:71-5.
32. Allansmith MR, Baird RS, Bloch KJ. Effect of anaphylaxis in conjunctival goblet cells. J Allergy Clin Immunol 1985;76:200-8.
33. Rothernberg ME, Owen WF, Stevens RL. Mast cells and eosinophils. Int Ophthalmol Clin 1988;28:267-74.
34. Gleich GJ, Loegering DA. Immunobiology of eosinophils. Annu Rev Immunol 1984;2:429-59.
35. Lederer JA, Liou JS, Todd MD, Glimcher LH, Lichtman AH. Regulation of cytokine gene expression in T helper cell subsets. J Immunol 1994;152:77-81.
36. O'Hehir RE, Garman RD, Greenstein JL, Lamb JR. The specificity and regulation of T-cell responsiveness to allergens. Annu Rev Immunol 1991;9:67-95.
37. Galli SJ. Biology of disease. New insights into "The riddle of the mast cells": microenvironmcntal regulation of the mast cell development and phenotypic heterogeneity. Lab Invest 1990;62:5-33.
38. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-64.
39. Elner VM, Strieter RM, Pavillack MA, et al. Human corneal interleukin-8. IL-1 and TNF-induced gene expression and secretion. Am J Pathol 1991;139:977-88.
40. Elner VM, Elner SG, Pavillack MA, Tood RF, Yue BYJT, Huber AR. Intercellular adhesion molecule-1 in human corneal endothelium. Am J Pathol 1991;138:525-36.
41. Bradding P, Feather IH, Wilson J et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5 and IL-6 in human allergic mucosal inflammation. J Immunol 1993;151:3853-65.
42. Benaurer WB, Wright P, Dart JK, Leonard JN, Lightman S. Cytokines in the conjunctiva of acute and chronic mucus membrane penphigoid: an immunohistochemical analysis. Graefes Arch Clin Exp Ophthalmol 1993;231:563-70.
43. Dvorak AM, Weller PF, Monahan-Earley RA, Letourneau L, Ackerman SJ. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab Invest 1990;62:590-607.
44. Resler B, Sedewick JB, Busse WW. Inhibition of interleukin-5 (IL-5) on human eosinophils (EOS) by nedocromil sodium (NED) [Abstract]. J Allergy Clin Immunol 1992;89:235.
45. Dvorak AM, Tepper RI, Weller PF, et al. Piecemeal degranulation of mast cells in the inflammatory eye lid lesions of IL-4 transgenic mice: evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood 1994;83:3600-12.
46. Teppler RI, Levinson A, Stanger BZ, Campos Torres J, Abbas AK, Leder P. TL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 1990;62:457-67.
47. Loh RK, Jabara HH, Geha RS. Cromolin sodium (CS) and nedocromil sodium (NS) inhibit Sμ-Sε deletional switch recombination and IgE synthesis in human B cells [Abstract]. J Allergy Clin Immunol 1994;93:219.